Manufacturer for Igm Antibody To Mycoplasma Pnumoniae - Hot selling Diagnostic Kit for Progesterone – Baysen
Manufacturer for Igm Antibody To Mycoplasma Pnumoniae - Hot selling Diagnostic Kit for Progesterone – Baysen Detail:
Diagnostic Kit for Progesterone
(fluorescence immunochromatographic assay)
For in vitro diagnostic use only
Please read this package insert carefully prior to use and strictly follow the instructions. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in this package insert.
INTENDED USE
Diagnostic Kit for Progesterone (fluorescence immunochromatographic assay) is a fluorescence immunochromatographic assay for the quantitative detection of Progesterone (PROG) in human serum or plasma, it is used for auxiliary diagnosis of progesterone abnormally associated diseases.All positive sample must be confirmed by other methodologies. This test is intended for healthcare professional use only.
Product detail pictures:




Related Product Guide:
Scientists have yet to find the Holy Grail of cancer tests | Cpn-Igm
There’s no justification for claiming new blood test is ’94% accurate’ compared to PSA test for prostate cancer | P24 Test Strips
We keep on with our enterprise spirit of "Quality, Efficiency, Innovation and Integrity". We intention to create extra worth for our buyers with our prosperous resources, superior machinery, experienced workers and superb services for Manufacturer for Igm Antibody To Mycoplasma Pnumoniae - Hot selling Diagnostic Kit for Progesterone – Baysen , The product will supply to all over the world, such as: Accra, Costa rica, Malaysia, we have 8 years experience of production and 5 years experience in trading with the customers all over the world. our clients mainly distributed in the North America, Africa and Eastern Europe. we can supply high quality products with the very competitive price.

High production efficiency and good product quality, fast delivery and completed after-sale protection, a right choice, a best choice.
